Energy metabolism in the normal and failing heart: potential for therapeutic interventions
- PMID: 11988636
- DOI: 10.1023/a:1015320423577
Energy metabolism in the normal and failing heart: potential for therapeutic interventions
Abstract
The chronically failing heart has been shown to be metabolically abnormal, in both animal models and in patients. Little data are available on the rate of myocardial glucose, lactate and fatty acid metabolism and oxidation in heart failure patients, thus at present, it is not possible to draw definitive conclusions about cardiac substrate preference in the various stages and manifestations of the disease. Normal cardiac function is dependent on a constant resynthesis of ATP by oxidative phosphorylation in the mitochondria. The healthy heart gets 60-90% of its energy for oxidative phosphorylation from fatty acid oxidation, with the balance from lactate and glucose. There is some indication that compensated NYHA Class III heart failure patients have a significantly greater rate of lipid oxidation, and decreased glucose uptake and carbohydrate oxidation compared to healthy age-matched individuals, and that therapies that acutely switch the substrate of the heart away from fatty acids result in improvement in left ventricular function. Clinical studies using long-term therapy with beta-adrenergic receptor antagonists show improved left ventricular function that corresponds with a switch away from fatty acid oxidation towards more carbohydrate oxidation by the heart. These findings suggest that chronic manipulation of myocardial substrate oxidation toward greater carbohydrate oxidation and less fatty acid oxidation may improve ventricular performance and slow the progression of left ventricular dysfunction in heart failure patients. At present, this intriguing hypothesis requires further evaluation.
Similar articles
-
Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.Biomed Pharmacother. 2010 Mar;64(3):203-7. doi: 10.1016/j.biopha.2009.10.002. Epub 2009 Nov 13. Biomed Pharmacother. 2010. PMID: 19954925 Review.
-
Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.Cardiovasc Res. 2010 Jun 1;86(3):461-70. doi: 10.1093/cvr/cvp414. Epub 2009 Dec 24. Cardiovasc Res. 2010. PMID: 20035032
-
Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.Curr Pharm Des. 2015;21(25):3654-64. doi: 10.2174/1381612821666150710150445. Curr Pharm Des. 2015. PMID: 26166604 Review.
-
Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.Semin Cardiothorac Vasc Anesth. 2006 Sep;10(3):228-30. doi: 10.1177/1089253206291150. Semin Cardiothorac Vasc Anesth. 2006. PMID: 16959756
-
Metabolic remodelling of the failing heart: beneficial or detrimental?Cardiovasc Res. 2009 Feb 15;81(3):420-8. doi: 10.1093/cvr/cvn282. Epub 2008 Oct 14. Cardiovasc Res. 2009. PMID: 18854380 Review.
Cited by
-
Impact of metabolism-related mutations on the heart rate of gastric cancer patients after peritoneal lavage.World J Clin Cases. 2021 Feb 26;9(6):1318-1328. doi: 10.12998/wjcc.v9.i6.1318. World J Clin Cases. 2021. PMID: 33644198 Free PMC article.
-
Hyperpolarized 13C Metabolic MRI of the Human Heart: Initial Experience.Circ Res. 2016 Nov 11;119(11):1177-1182. doi: 10.1161/CIRCRESAHA.116.309769. Epub 2016 Sep 15. Circ Res. 2016. PMID: 27635086 Free PMC article. Clinical Trial.
-
Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats.Cell Physiol Biochem. 2012;29(5-6):841-50. doi: 10.1159/000178526. Epub 2012 May 11. Cell Physiol Biochem. 2012. PMID: 22613984 Free PMC article.
-
Expression of mitochondrial protein genes encoded by nuclear and mitochondrial genomes correlate with energy metabolism in dairy cattle.BMC Genomics. 2020 Oct 19;21(1):720. doi: 10.1186/s12864-020-07018-7. BMC Genomics. 2020. PMID: 33076826 Free PMC article.
-
The critical role of Astragalus polysaccharides for the improvement of PPARα [ correction of PPRAα]-mediated lipotoxicity in diabetic cardiomyopathy.PLoS One. 2012;7(10):e45541. doi: 10.1371/journal.pone.0045541. Epub 2012 Oct 1. PLoS One. 2012. PMID: 23049681 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical